BANGKOK (Reuters): The chair of Thailand's Thonburi Healthcare Group (THG) said on Wednesday (Aug 4) that a deal to import 20 million doses of the Pfizer-BioNTech Covid-19 vaccine was unlikely to happen, despite his earlier claims that a deal was close.
Thailand is battling its biggest Covid-19 outbreak yet, and has been racing to secure vaccines. Last month, THG Chairman Boon Vanasin said talks to clinch a deal with BioNTech was nearing conclusion, but both Pfizer and BioNTench said they were not in talks with THG.